Editorial Board
26 September 2009 | page i
Viewing articles 1-7 of 7
26 September 2009 | pages 785 - 786
Metastatic Renal Cell Carcinoma: Pathogenesis and the Current Medical Landscape
26 September 2009 | pages 787 - 792
Molecular Pathways in Metastatic Renal Cell Carcinoma: The Evolving Role of Mammalian Target of Rapamycin Inhibitors
26 September 2009 | pages 793 - 798
26 September 2009 | pages 799 - 808
Treatment Algorithms in Metastatic Renal Cell Carcinoma, Including the Potential Role of the Novel Oral Mammalian Target of Rapamycin Inhibitor Everolimus
26 September 2009 | pages 809 - 814
Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma
26 September 2009 | pages 815 - 819
Viewing articles 1-7 of 7